Catalyst
Slingshot members are tracking this event:
Mylan Confirms FDA Submission of ANDA for Generic version of GlaxoSmithKline's Advair Diskus
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MYL |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Submission, Fluticasone Propionate, Salmeterol, Advair Diskus, Asthma, Airflow Obstruction, Chronic Obstructive Pulmonary Disease, Copd
